RARE · Ultragenyx Pharmaceutical Inc. · Documents
$16.08
+0.43 (+2.75%)
At close · Oct 26
Return incl. dividend (before tax)
Market Cap
$1.54B
Shares
98.59M
Volume · Oct 26
3.02M
Avg daily vol (3M)
4.12M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| ARS | — | 2025-03-28 | 2024-12-31 | |
| DEFA14A | — | 2025-03-28 | — | |
| 10-K | — | 2025-02-19 | 2024-12-31 | |
| 8-K | — | 2025-02-13 | — | |
| 8-K | — | 2025-01-13 | 2025-01-12 | |
| 8-K | — | 2024-12-19 | — | |
| 8-K | — | 2024-12-19 | — | |
| 8-K | — | 2024-11-12 | 2024-11-09 | |
| 10-Q | — | 2024-11-06 | 2024-09-30 | |
| 8-K | — | 2024-11-05 | — | |
| 8-K | — | 2024-10-07 | — | |
| 8-K | — | 2024-10-03 | — | |
| 10-Q | — | 2024-08-02 | 2024-06-30 | |
| 8-K | — | 2024-08-01 | — | |
| 8-K | — | 2024-07-17 | — | |
| 8-K | — | 2024-06-21 | 2024-06-18 | |
| 8-K | — | 2024-06-17 | 2024-06-13 | |
| 8-K | — | 2024-06-12 | 2024-06-11 | |
| 8-K | — | 2024-06-12 | — | |
| 8-K | — | 2024-05-30 | — | |
| 10-Q | — | 2024-05-03 | 2024-03-31 | |
| 8-K | — | 2024-05-02 | — | |
| ARS | — | 2024-04-26 | 2023-12-31 | |
| DEFA14A | — | 2024-04-26 | — | |
| DEF 14A | — | 2024-04-26 | 2024-06-18 | |
| 8-K | — | 2024-04-15 | — | |
| 10-K | — | 2024-02-21 | 2023-12-31 | |
| S-3ASR | — | 2024-02-21 | — | |
| 8-K | — | 2024-02-15 | — | |
| 8-K | — | 2024-01-08 | 2024-01-07 | |
| 8-K | — | 2023-12-21 | 2023-12-15 | |
| 10-Q | — | 2023-11-03 | 2023-09-30 | |
| 8-K | — | 2023-11-02 | — | |
| 8-K | — | 2023-10-23 | 2023-10-18 | |
| 8-K | — | 2023-10-16 | 2023-10-14 | |
| 8-K | — | 2023-09-08 | 2023-09-06 | |
| 10-Q | — | 2023-08-04 | 2023-06-30 | |
| 8-K | — | 2023-08-03 | — | |
| 8-K | — | 2023-07-12 | — | |
| 8-K | — | 2023-07-06 | — | |
| 8-K | — | 2023-06-13 | 2023-06-07 | |
| 8-K | — | 2023-06-05 | — | |
| 8-K | — | 2023-05-17 | — | |
| 10-Q | — | 2023-05-05 | 2023-03-31 | |
| 8-K | — | 2023-05-04 | — | |
| DEFA14A | — | 2023-04-24 | — | |
| DEF 14A | — | 2023-04-24 | — | |
| 8-K | — | 2023-03-23 | 2023-03-20 | |
| 8-K | — | 2023-03-14 | — | |
| 10-K | — | 2023-02-17 | 2022-12-31 |
Showing 51–100 of 171 filings
Key facts
CIK
1515673
CUSIP
90400D108
13F (30d)
26 filings
26 filers
Visit website
Investor relations